Type of GLP-1 RA used (liraglutide, semaglutide, dulaglutide)
Oropharma Carmine is a liquid carnitine preparation enriched with vitamins, amino acids, and choline
Important Medical Disclaimer GLP-1 receptor agonists are currently approved regulatory indications for the management of Type 2 diabetes mellitus and obesity
Patients should seek immediate medical attention for and discontinue semaglutide if they experience: Severe, persistent abdominal pain (possible pancreatitis) Signs of thyroid tumors (neck mass, difficulty swallowing, persistent hoarseness) Symptoms of gallbladder disease (right upper quadrant pain, especially after meals) Severe hypoglycemia (when combined with insulin or sulfonylureas) Signs of kidney problems (decreased urination, swelling, fatigue) Suicidal thoughts or behaviors (particularly with Wegovy) Vision changes (especially in patients with diabetes and pre-existing retinopathy) Regular follow-up with healthcare providers is essential to monitor treatment response, adjust dosing, manage side effects, and assess cardiovascular risk factors including blood pressure, glucose control, and lipid profiles